|
1.
|
Yu H, Ok CY, Hesse A, Nordell P, Connor D, Sjostedt E, Pechet L, Michael Snyder L. Evaluation of an automated digital imaging system, nextslide digital review network, for examination of peripheral blood smears. Arch Pathol Lab Med. 2012 Jun; 136(6):660-7.
|
|
|
|
|
2.
|
Jaffar R, Pechet L, Whalen GF, Banner BF. Spontaneous hepatic hemorrhage secondary to prolonged use of oral contraceptives. Pathol Res Pract. 2010 May 15; 206(5):318-21.
|
|
|
|
|
3.
|
Tang G, Woods LJ, Wang SA, Brettler D, Andersen M, Miron PM, Pechet L, Woda BA, Hao S. Chronic basophilic leukemia: a rare form of chronic myeloproliferative neoplasm. Hum Pathol. 2009 Aug; 40(8):1194-9.
|
|
|
|
|
4.
|
Liu J, Hutzler M, Li C, Pechet L. Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS): the new thinking. J Thromb Thrombolysis. 2001 May; 11(3):261-72.
|
|
|
|
|
5.
|
Rosenwald IB, Pechet L, Han A, Lu L, Pihan G, Woda B, Chen JJ, Szymanski I. Expression of translation initiation factors elF-4E and elF-2alpha and a potential physiologic role of continuous protein synthesis in human platelets. Thromb Haemost. 2001 Jan; 85(1):142-51.
|
|
|
|
|
6.
|
Yu M, Nardella A, Pechet L. Screening tests of disseminated intravascular coagulation: guidelines for rapid and specific laboratory diagnosis. Crit Care Med. 2000 Jun; 28(6):1777-80.
|
|
|
|
|
7.
|
Senno SL, Pechet L. Clinical implications of elevated PAI-1 revisited: multiple arterial thrombosis in a patient with essential thrombocythemia and elevated plasminogen activator inhibitor-1 (PAI-1) levels: a case report and review of the literature. J Thromb Thrombolysis. 1999 Aug; 8(2):105-12.
|
|
|
|
|
8.
|
Misialek MJ, Pechet L. A diagnostic dilemma: chronic myelomonocytic leukemia versus atypical chronic myeloid leukemia. A case report and review of the literature. Acta Haematol. 1997; 98(4):221-7.
|
|
|
|
|
9.
|
Patiño-Sarcinelli F, Knecht H, Pechet L, Pihan G, Savas L, Snyder LM. Leukemia with megakaryocytic differentiation following essential thrombocythemia and myelofibrosis. Case report and review of the literature. Acta Haematol. 1996; 95(2):122-8.
|
|
|
|
|
10.
|
Nardella A, Pechet L, Snyder LM. Continuous improvement, quality control, and cost containment in clinical laboratory testing. Effects of establishing and implementing guidelines for preoperative tests. Arch Pathol Lab Med. 1995 Jun; 119(6):518-22.
|
|
|
|
|
11.
|
Griffiths EB, Pechet L, Snyder LM. A laboratory rotation for medical house officers. Bridging the gap. Arch Pathol Lab Med. 1995 May; 119(5):480-2.
|
|
|
|
|
12.
|
Nardella A, Farrell M, Pechet L, Snyder LM. Continuous improvement, quality control, and cost containment in clinical laboratory testing. Enhancement of physicians' laboratory-ordering practices. Arch Pathol Lab Med. 1994 Oct; 118(10):965-8.
|
|
|
|
|
13.
|
Tiarks C, Pechet L, Anderson J, Mole JE, Humphreys RE. Characterization of a factor VIII immunogenic site using factor VIII synthetic peptide 1687-1695 and rabbit anti-peptide antibodies. Thromb Res. 1992 Feb 1; 65(3):301-10.
|
|
|
|
|
14.
|
Tiarks CY, Humphreys RE, Pechet L. Factor VIII epitopes recognized with inhibitory monoclonal antibodies. Acta Haematol. 1990; 83(2):69-75.
|
|
|
|
|
15.
|
Tiarks C, Pechet L, Humphreys RE. Development of anti-idiotypic antibodies in a patient with a factor VIII autoantibody. Am J Hematol. 1989 Nov; 32(3):217-21.
|
|
|
|
|
16.
|
Lock JP, Castro GA, Pechet LN, Snyder LM. Hemodialysis in myelomatosis. Ann Intern Med. 1973 Mar; 78(3):454.
|
|
|
|
